Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 104746 04 5. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel asymmetric catalytic method for Eslicarbazepine production. Reduces operational cost and improves supply chain reliability for global pharmaceutical intermediates.
Patent CN110790708A details a novel iridium-catalyzed asymmetric hydrogenation route for Eslicarbazepine intermediates, offering high enantioselectivity and atom economy for pharmaceutical manufacturing.